Be in the know. 20 key reads for Monday…

  1. China’s securities regulator ready to communicate with US counterparts on audit oversight cooperation (shine)
  2. China’s central bank cuts a benchmark rate for the first time since the pandemic (cnbc)
  3. China asks lenders to step up bond issuances, loans to boost property sector M&A (scmp)
  4. Stocks will roar higher into year-end and January as an ‘overshoot’ in selling leads to a short squeeze, JPMorgan’s quant guru says (businessinsider)
  5. Manchin Says ‘No’ on Biden’s Build Back Better Plan (barrons)
  6. Goldman Sachs Cuts U.S. Growth Forecast After Manchin Rejects Build Back Better Plan (barrons)
  7. Interest Rates Are Rising—but the Fed’s Actions Could Make It Easier to Get a Mortgage (barrons)
  8. Carnival Cruise CEO’s Goal: A Full Fleet Sailing by Summer (barrons)
  9. Rising Interest Rates and a Growing Economy Will Lift Bank Stocks (barrons)
  10. Stock buybacks can keep surging next year after a potential record for 2021, analysts say (marketwatch)
  11. Omicron For Christmas. The Energy Report 12/20/2021 (Phil Flynn)
  12. Tiger Woods looks ready to win again — and he will (nypost)
  13. Two industrials stocks caught up in market weakness look like buys heading into 2022, traders say (cnbc)
  14. Biogen to lower price of Alzheimer’s drug aduhlem by 50% starting Jan. 1 to about $28,200 a year (marketwatch)
  15. Opinion: Inflation-adjusted Treasury yields are lower than they’ve been in 70 years. Here’s why that isn’t a bigger negative for stocks (marketwatch)
  16. UPDATE: Bluebird Bio announces partial clinical hold for patients under 18 in sickle cell gene therapy program (marketwatch)
  17. BofA Securities Out With Its 11 Top Stock Picks for 2022 (247wallst)
  18. China cuts lending benchmark, market sees more easing in 2022 (reuters)
  19. The Bond Market Isn’t Buying Fed’s Sketch of Rate Hike Plans (bloomberg)
  20. The Big Read. Supply chains: companies shift from ‘just in time’ to ‘just in case’ (ft)